Cost effectiveness of detecting Barrett's cancer

Gut

Volumn 39, Issue 4, 1996, Pages 574-579

  Wright, T A ^a,c   Gray, M R ^a   Morris, A I ^a   Gilmore, I T ^a   Ellis, A ^b   Smart, H L ^b   Myskow, M ^b   Nash, J ^a   Donnelly, R J ^b   Kingsnorth, A N ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Broadgreen Hospital   (United Kingdom)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

Barrett oesophagus; Cost effectiveness; Cost benefit analysis; Oesophageal neoplasms; Precancerous conditions

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; ESOPHAGUS CANCER; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

EID: 19244364907     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.4.574     Document Type: Article

References (14)

1. Naef AP, Savary M, Ozzellp L. Columnar-lined lower esophagus:an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975; 70: 826-35.
2. Iascone C, DeMeester TR, Little AG, Skinner DB. Barrett's esophagus: functional assessment, proposed pathogenesis and surgical therapy. Arch Surg 1983; 118: 543-9.
3. Winters C, Spurling TJ, Chobanian SJ, Curtis D, Esposito RL, Hacker JF, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-24.
4. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-22.
5. Skinner DB, Walther EC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554-66.
6. Cooper BT, Barbezat GO. Barrett's oesophagus: a clinical study of 52 patients. Q J Med 1987; 238: 98-108.
7. Atkinson M, Iftikhar SY, James PD, Robertson CS, Steele RJC. The early diagnosis of oesophageal adenocarcinoma by endoscopic screening. Eur J Cancer Prev 1992; 1: 327-30.
8. Spechler SJ, Robbins AH, Bloomfield R, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87: 927-33.
9. Sprung DJ, Ellis FH, Gibb SP. Incidence of adenocarcinoma in Barrett's esophagus (abstract). Am J Gastroenterol 1984; 79: 817.
10. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313(14): 857-9.
11. Sampliner RE, Kogan FJ, Morgan TR, Tripp M. Progression-regression of Barrett's esophagus (abstract). Gastroenterology 1985; 88: 1567.
12. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988; 83: 291-4.
13. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75: 760-3.
14. Van Der Veen AH, Dees J, Blankenstein JD, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-18.